SciTransfer
Organization

VASTRA GOTALANDSREGIONEN

Swedish regional authority contributing clinical healthcare infrastructure, paediatric research capacity, and policy implementation to European health and cultural heritage consortia.

Public authorityhealthSE
H2020 projects
16
As coordinator
1
Total EC funding
€3.6M
Unique partners
325
What they do

Their core work

Västra Götalandsregionen is the regional government authority for Sweden's second-largest region, responsible for healthcare delivery, regional development, and research infrastructure across western Sweden. In H2020, they bring clinical healthcare capacity — particularly in paediatrics, stroke care, and elderly care — into European research consortia. They also drive regional innovation policy through triple-helix collaboration linking universities, industry, and public services, and have expanded into cultural heritage and sustainable tourism planning.

Core expertise

What they specialise in

Paediatric clinical research and drug developmentprimary
3 projects

Core contributor to c4c (collaborative paediatric clinical trials network), ChiLTERN (children's liver tumour research), and ID-EPTRI (paediatric translational research infrastructure).

Healthcare for elderly and cognitive accessibilityprimary
3 projects

Participated in IN LIFE (independent living for elderly), DECI (digital cognitive inclusion), and Easy Reading (personalised cognitive accessibility).

Regional innovation and researcher mobilitysecondary
1 project

Coordinated MoRE2020, their only coordinator role, focused on researcher mobility, smart specialisation, and triple-helix regional clusters in Västra Götaland.

Cultural heritage and sustainable tourismemerging
2 projects

Partner in HERILAND (heritage landscape planning) and participant in Be.CULTOUR (circular cultural tourism with human-centred innovation).

Clinical medicine — stroke and radiationsecondary
2 projects

Contributed to PROOF (stroke neuroprotection via normobaric oxygen) and MEDIRAD (medical low-dose radiation exposure implications).

Evolution & trajectory

How they've shifted over time

Early focus
Elderly care and regional innovation
Recent focus
Paediatric clinical trials and cultural heritage

Early H2020 work (2015–2018) centred on elderly care, cognitive inclusion, and basic clinical participation — projects like IN LIFE, DECI, and EUthyroid — alongside a flagship researcher mobility programme (MoRE2020). From 2018 onward, the focus sharpened toward paediatric drug development and clinical trial infrastructure (c4c, ID-EPTRI), while a new thread in cultural heritage and circular tourism emerged (HERILAND, Be.CULTOUR). The shift suggests a deliberate move from broad health/social innovation toward more specialized clinical research roles and diversification into culture-related policy domains.

Moving toward deeper clinical research specialisation in paediatrics while exploring cultural heritage as a secondary policy-driven research line.

Collaboration profile

How they like to work

Role: active_partnerReach: European37 countries collaborated

Västra Götalandsregionen overwhelmingly participates rather than leads — coordinating only 1 of 16 projects (MoRE2020, a researcher mobility programme suited to a regional authority). With 325 unique partners across 37 countries, they operate as a wide-network contributor embedded in large European consortia rather than a tight-knit repeat-partner hub. This makes them a reliable, low-ego consortium member who brings real-world clinical and policy infrastructure without competing for leadership.

Extensive European network spanning 325 unique partners across 37 countries, reflecting the breadth of large-scale health and innovation consortia. No strong geographic clustering — they are genuinely pan-European in their collaborations.

Why partner with them

What sets them apart

As a regional government running actual hospitals and public services, they offer something most academic partners cannot: direct access to patient populations, clinical infrastructure, and real-world implementation environments. Their dual track in health and cultural heritage makes them unusually versatile for a public body. For consortium builders, they are a credible end-user and policy-implementation partner who can demonstrate societal impact in grant applications.

Notable projects

Highlights from their portfolio

  • MoRE2020
    Their only coordinator role and largest single grant (EUR 708,000), a MSCA-COFUND programme building researcher mobility and smart specialisation in the Västra Götaland region.
  • c4c
    Largest total funding (EUR 632,761) in a major pan-European paediatric clinical trials network running through 2025, signalling deep commitment to this field.
  • Be.CULTOUR
    Represents a strategic pivot into circular cultural tourism with EUR 229,312 funding, showing diversification beyond their traditional health domain.
Cross-sector capabilities
Cultural heritage and sustainable tourism planningDigital inclusion and cognitive accessibilityBlue bioeconomy (via ERA-NET participation)Regional innovation policy and smart specialisation
Analysis note: Profile is moderately confident. While 16 projects provide a reasonable picture, many early projects lack keywords, limiting the granularity of expertise mapping. The organization's real-world clinical and policy capacity is likely much broader than what H2020 participation alone reveals. No website was provided in the data, which limits verification of current priorities.